Skip to main content

Table 1 Baseline characteristics of patients with and without a MACCE after CABG surgery

From: Depression, anxiety and major adverse cardiovascular and cerebrovascular events in patients following coronary artery bypass graft surgery: a five year longitudinal cohort study

Descriptive variables Total N (%)a No MACCE (n = 121) MACCE (n = 37) P
Age, M ± SD 64.7 ± 10.6 63.7 ± 10.5 67.8 ± 10.4 .04
Female 33 (20.9) 26 (21.5) 7 (18.9) .74
Aboriginal 6 (3.8) 3 (2.5) 3 (8.1) .14
BMI, M ± SD 29.1 ± 5.2 29.3 ± 5.0 28.6 ± 5.6 .47
Concomitant valvular procedure 18 (11.4) 12 (9.9) 6 (16.2) .29
Urgent surgery 34 (21.5) 28 (23.1) 6 (16.2) .37
Previous MI <30 days 51 (32.3) 39 (32.2) 12 (32.4) .98
LVEF 45 – 60 % 33 (20.9) 22 (18.2) 11 (29.7) .39
30 – 45 % 12 (7.4) 9 (7.4) 3 (8.1)  
<30 % 6 (3.3) 4 (3.3) 2 (5.4)  
Hypertension 102 (64.6) 73 (60.3) 29 (78.4) .04
Hypercholesterolemia 118 (74.7) 91 (75.2) 27 (73.0) .79
Diabetes, Type 1 2 (1.3) 2 (1.7) - .63
Type 2 48 (30.4) 38 (31.4) 10 (27.0)  
Chronic lung disease 33 (20.9) 27 (22.3) 6 (16.2) .43
Renal disease 11 (7.0) 6 (5.0) 5 (13.5) .07
Heart failure 40 (25.3) 26 (21.5) 14 (37.8) .04
Peripheral vascular disease 18 (11.4) 10 (8.3) 8 (21.6) .03
Cerebrovascular disease 16 (10.1) 12 (9.9) 4 (10.8) .88
Tobacco smoking 94 (59.5) 73 (60.3) 21 (56.8) .70
SSRI 6 (3.8) 4 (3.3) 2 (5.4) .63
Tricyclic 3 (1.9) 1 (0.8) 2 (5.4) .14
Aspirin 122 (77.2) 91 (75.2) 31 (83.8) .28
EuroSCORE, Median (IQR) 2.6 (1.5 – 4.7) 2.5 (1.5 – 4.4) 3.1 (2.0 – 6.6) .24
Pre-CPB Hb, M ± SD 13.9 ± 1.7 14.0 ± 1.7 13.5 ± 2.0 .17
Minutes spent on CPB Median (IQR) 56.0 (42.8 – 73.0) 57.0 (46.0 – 73.0) 52.0 (36.5 – 74.5) .30
ICU LOS, median hours (IQR) 25.7 (23 – 47.5) 25.7 (23.0 – 48.4) 25.7 (23.6 – 27.6) .97
ICU intubation, median hours (IQR) 12.5 (10.1 – 17.0) 12.2 (9.6 – 16.4) 14.2 (11.5 – 22.0) .13
  1. aData presented as N (%) unless otherwise specified
  2. BMI body mass index, CABG coronary artery bypass graft surgery, CPB cardiopulmonary bypass, ICU intensive care unit, IQR interquartile range, LVEF left ventricular ejection fraction, LOS length of stay, M ± SD mean ± standard deviation, MACCE major adverse cardiovascular and cerebrovascular events, MI myocardial infarction, SSRI selective serotonin re-uptake inhibitor
\